Saifi et al., 2023 - Google Patents
A Tour-d'Horizon of microbiota therapeutics for metabolic disordersSaifi et al., 2023
- Document ID
- 1047660417144765837
- Author
- Saifi S
- Swaminathan A
- Devi P
- Chattopadhyay P
- Gupta S
- Garg A
- Saxena S
- Parveen S
- Pandey R
- Publication year
- Publication venue
- Microbiome Therapeutics
External Links
Snippet
The human gut microbiota consists of nearly 10 14 microbes. They are involved in modulating a myriad of physiological and metabolic pathways within the host. The interaction between the host and the microbial community plays a significant role in the …
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER, CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using micro-organisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using micro-organisms or enzymes using only micro-organisms of the genus lactobacteriaceae; Yoghurt
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A23B - A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23Y—INDEXING SCHEME RELATING TO LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23Y2220/00—Lactobacillus
- A23Y2220/73—Rhamnosus
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Vallianou et al. | Probiotics, prebiotics, synbiotics, postbiotics, and obesity: current evidence, controversies, and perspectives | |
| Davis | The gut microbiome and its role in obesity | |
| Khalighi et al. | Probiotics: a comprehensive review of their classification, mode of action and role in human nutrition | |
| Macfarlane | Prebiotics in the gastrointestinal tract | |
| Hays et al. | Probiotics and growth in preterm infants: a randomized controlled trial, PREMAPRO study | |
| Ceapa et al. | Influence of fermented milk products, prebiotics and probiotics on microbiota composition and health | |
| US10543239B2 (en) | Lactic acid bacteria and bifidobacteria for treating endotoxemia | |
| EP2442814B1 (en) | Bifidobacteria for treating diabetes and related conditions | |
| KR101982491B1 (en) | Method for preventing and/or treating insulin resistance | |
| TWI572354B (en) | Composition for suppressing inflammation | |
| Tamboli et al. | Probiotics in inflammatory bowel disease: a critical review | |
| Caimari et al. | Heat-killed Bifidobacterium animalis subsp. Lactis CECT 8145 increases lean mass and ameliorates metabolic syndrome in cafeteria-fed obese rats | |
| Quigley | Nutraceuticals as modulators of gut microbiota: Role in therapy | |
| JP2009511469A (en) | Probiotics affecting fat metabolism and obesity | |
| Hickey et al. | Probiotics in neonatology | |
| KR20190116248A (en) | New Probiotic Bifidobacterium Strains | |
| Taherian et al. | An overview on probiotics as an alternative strategy for prevention and treatment of human diseases | |
| Arora et al. | Therapeutic potential of probiotics: A ray of hope or nightmare? | |
| Perna et al. | Is Probiotic Supplementation Useful for the Management of Body Weight and Other Anthropometric Measures in Adults Affected by Overweight and Obesity with Metabolic Related Diseases? A Systematic Review and Meta-Analysis. Nutrients [online] 2021 Feb 19 [cited 2021 July 11]; 13 (2): 1-18 | |
| Saifi et al. | A Tour-d’Horizon of microbiota therapeutics for metabolic disorders | |
| Lahtinen et al. | Lactobacillus species causing obesity in humans: where is the evidence? | |
| Reehana et al. | Synbiotics in Nutrition | |
| Leo et al. | Probiotics beverages: An alternative treatment for metabolic syndrome | |
| Rackerby et al. | Effects of Diet on Human Gut Microbiome and Subsequent Influence on Host Physiology and Metabolism | |
| Nunes | Probiotics and enzymes in the gastrointestinal tract |